Health CanadaGeneral Alert
Kadcyla (trastuzumab emtansine) and Herceptin (trastuzumab) - Potential Risk for...
Published: October 9, 2013Recall ID: 50526Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Kadcyla (trastuzumab emtansine) and Herceptin (trastuzumab) - Potential Risk for Medication Error Due to Name Confusion - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 50526 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/kadcyla-trastuzumab-emtansine-and-herceptin-trastuzumab-potential-risk-medication |
| Issue | Product safety |
| Title | Kadcyla (trastuzumab emtansine) and Herceptin (trastuzumab) - Potential Risk for Medication Error Due to Name Confusion - For Health Professionals |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2013-10-09 |
| Organization | Marketed health products |